Abstract:Two-dimensional cell lines display a wide range of usability and are readily available in a pandemic for identifying potential pathways of infection and tissue tropism of human pathogens. SARS-CoV-2 cultured in Vero-E6 cells (monkey kidney cells) showed high sequence homology and morphology similarity compared to viruses inoculated in human airway epithelial cells [3,4]. In addition, Vero-E6 cells enable higher level of SARS-CoV-2 amplification and infectivity compared to several human cell lines including A549, Calu-3, HUH7.9, HEK-293, and U251, suggesting its usefulness in generating viral stocks for translational research [5,6]. HEK-293 cells (human embryonic kidney cells) enabled the identification of S1 and S2 subunits of the SARS-CoV-2 transmembrane spike glycoprotein as the ligands that bind host receptors [7]. Using Vero-E6 cells, these subunits were also shown to be involved in viral fusion to host cell membrane to establish infection [8]. Consequently, these cell lines have been used to evaluate drugs and vaccines response [9]. In vitro cell models also enabled the identification of host factors that are involved in SARS-CoV-2 infection. Using parental BHK-21 cells (hamster-derived), the importance of angiotensin-converting enzyme 2 (ACE2) receptor in mediating infection has been discovered [7,10]. Using human HeLa cells, several proteases including transmembrane protease serine 2 and lysosomal protease cathepsin were identified as essential determinants of viral infectivity [7,10]. In addition, genome-wide CRISPR screens in various cell lines have identified functional pathways that are involved in SARS-CoV-2 infection. Screening in Vero-E6 cells led to the discovery of several proviral genes such as HMGB1 (which plays a role in regulating ACE2 expression, hence may affect viral entry into host cells) [11] and CDK4 (which is involved in cell cycle regulation that is crucial for viral replication) [12]. Using the same cell line and technique, the SWI/SNF chromatin remodeling complex has also been identified as proviral, while the Histone H3.3 complex was proposed to have an antiviral role in SARS-CoV-2 infection [11]. While the use of 2D cellular models in research has significantly advanced our understanding on SARS-CoV-2 pathogenesis, there are several noteworthy limitations. These cell lines do not mimic the complexity of the tissue microenvironment and the in vivo conditions in the human primary airway because they are often monocultures of immortalized cells, and some are of animal origins [13,14]. For example, they may not reproduce the antiviral responses in the lungs during an infection. In addition, long-term passaging of SARS-CoV-2 in permissive cell lines may induce mutations that alter the viruses' original pathogenicity and transmissibility, thus overtime may no longer be usable for research (Fig 1A) [6,15]. Ultimately, reducing capacities to translate novel basic science discoveries to clinical trials, and some of these limitations can be addressed using 3D cultures, which are discussed in later section.

Air exposure and cell differentiation are essential for investigation of SARS-CoV-2 entry genes in human primary airway epithelial cells in vitro

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology

Lung Cancer Models Reveal SARS-CoV-2-induced EMT Contributes to COVID-19 Pathophysiology

Determinants of SARS-CoV-2 Receptor Gene Expression in Upper and Lower Airways

Sars-Cov-2 Infection Induces Emt-Like Molecular Changes, Including Zeb1-Mediated Repression Of The Viral Receptor Ace2, In Lung Cancer Models

The Transcriptome Landscape of the In Vitro Human Airway Epithelium Response to SARS-CoV-2

Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection

Single-cell analysis of human lung epithelia reveals concomitant expression of the SARS-CoV-2 receptor ACE2 with multiple virus receptors and scavengers in alveolar type II cells

Airway models in a pandemic: Suitability of models in modeling SARS-CoV-2

Growth media affects susceptibility of air-lifted human nasal epithelial cell cultures to SARS-CoV2, but not Influenza A, virus infection

SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response

Single-cell RNA-seq data analysis characterizing bronchoalveolar epithelial cells in patients with SARS-CoV-2 infection

1735P SARS-CoV-2 Infection Induces EMT-like Molecular Changes, Including ZEB1-mediated Repression of the Viral Receptor ACE2, in Lung Cancer Models

Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects

SARS-CoV-2 Entry Genes Are Most Highly Expressed in Nasal Goblet and Ciliated Cells within Human Airways

SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues

Long-Term Modeling of SARS-CoV-2 Infection of in Vitro Cultured Polarized Human Airway Epithelium

Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus

Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication

SARS-CoV-2 Virion Infectivity and Cytokine Production in Primary Human Airway Epithelial Cells

Comparative analysis of ACE2 protein expression in rodent, non-human primate, and human respiratory tract at baseline and after injury: A conundrum for COVID-19 pathogenesis